Heritage Trust CO Moderna, Inc. Transaction History

Heritage Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $216,262 - $292,967	-1,825 Reduced 41.59%	2,563 $311,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $20,620 - $29,947	-152 Reduced 3.35%	4,388 $673,000
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $46,878 - $83,175	396 Added 9.56%	4,540 $815,000
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $59,979 - $98,643	-508 Reduced 10.92%	4,144 $490,000
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $94,523 - $142,508	807 Added 20.99%	4,652 $665,000
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $54,630 - $101,541	432 Added 12.66%	3,845 $662,000
Q4 2021 Feb 09, 2022	BUY	$225.82 - $368.51 $22,807 - $37,219	101 Added 3.05%	3,413 $867,000
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $94,529 - $206,384	426 Added 14.76%	3,312 $1.27 Million
Q2 2021 Aug 09, 2021	BUY	$129.91 - $234.98 $41,181 - $74,488	317 Added 12.34%	2,886 $678,000
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $280,483 - $477,782	2,569 New	2,569 $336,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Heritage Trust CO, based on Form 13F filings with the SEC.

Stay updated on Heritage Trust CO with notifications on news.